STAGE IV DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8
Clinical trials for STAGE IV DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo trial offers hope for Tough-to-Treat thyroid cancer
Disease control OngoingThis study is testing whether two targeted cancer drugs (encorafenib and binimetinib), given with or without an immunotherapy drug (nivolumab), can help control advanced thyroid cancer that has a specific genetic change (BRAF V600 mutation) and has stopped responding to standard …
Matched conditions: STAGE IV DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New combo therapy trial offers hope for HIV patients with advanced cancers
Disease control OngoingThis is a small, early-stage safety study testing a combination of two cancer drugs, nivolumab and cabozantinib, in people living with HIV who have advanced solid tumors. The main goal is to see if the two-drug combination is safe and tolerable for this specific patient group. Re…
Matched conditions: STAGE IV DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC